These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 9565440
1. Early dexamethasone therapy in preterm infants: a follow-up study. Yeh TF, Lin YJ, Huang CC, Chen YJ, Lin CH, Lin HC, Hsieh WS, Lien YJ. Pediatrics; 1998 May; 101(5):E7. PubMed ID: 9565440 [Abstract] [Full Text] [Related]
2. Outcomes at school age after postnatal dexamethasone therapy for lung disease of prematurity. Yeh TF, Lin YJ, Lin HC, Huang CC, Hsieh WS, Lin CH, Tsai CH. N Engl J Med; 2004 Mar 25; 350(13):1304-13. PubMed ID: 15044641 [Abstract] [Full Text] [Related]
3. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY, Kao HA, Chien CH. Pediatrics; 1997 Oct 25; 100(4):E3. PubMed ID: 9310536 [Abstract] [Full Text] [Related]
4. Follow-up at 15 years of preterm infants from a controlled trial of moderately early dexamethasone for the prevention of chronic lung disease. Gross SJ, Anbar RD, Mettelman BB. Pediatrics; 2005 Mar 25; 115(3):681-7. PubMed ID: 15741372 [Abstract] [Full Text] [Related]
5. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL, Ehrenkranz RA. Cochrane Database Syst Rev; 2000 Mar 25; (2):CD001146. PubMed ID: 10796252 [Abstract] [Full Text] [Related]
6. The effects of early postnatal dexamethasone therapy on pulmonary outcome in premature infants with respiratory distress syndrome: a two-year follow-up study. Lin YJ, Lin CH, Wu JM, Tsai WH, Yeh TF. Acta Paediatr; 2005 Mar 25; 94(3):310-6. PubMed ID: 16028649 [Abstract] [Full Text] [Related]
7. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001146. PubMed ID: 24825456 [Abstract] [Full Text] [Related]
8. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Durand M, Sardesai S, McEvoy C. Pediatrics; 1995 Apr 13; 95(4):584-90. PubMed ID: 7700763 [Abstract] [Full Text] [Related]
9. Controlled trial of early dexamethasone treatment for the prevention of chronic lung disease in preterm infants: a 3-year follow-up. Romagnoli C, Zecca E, Luciano R, Torrioli G, Tortorolo G. Pediatrics; 2002 Jun 13; 109(6):e85. PubMed ID: 12042579 [Abstract] [Full Text] [Related]
10. Prevention of chronic lung disease in preterm infants by early postnatal dexamethasone therapy. Lin YJ, Yeh TF, Hsieh WS, Chi YC, Lin HC, Lin CH. Pediatr Pulmonol; 1999 Jan 13; 27(1):21-6. PubMed ID: 10023787 [Abstract] [Full Text] [Related]
11. Early (4-7 days of age) dexamethasone therapy for prevention of chronic lung disease in preterm infants. Tsukahara H, Watanabe Y, Yasutomi M, Kobata R, Tamura S, Kimura K, Hiraoka M, Mayumi M. Biol Neonate; 1999 Nov 13; 76(5):283-90. PubMed ID: 10516395 [Abstract] [Full Text] [Related]
12. Early dexamethasone therapy and blood cell count in preterm infants. Peng CT, Lin HC, Lin YJ, Tsai CH, Yeh TF. Pediatrics; 1999 Sep 13; 104(3 Pt 1):476-81. PubMed ID: 10469772 [Abstract] [Full Text] [Related]
13. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Shinwell ES, Karplus M, Reich D, Weintraub Z, Blazer S, Bader D, Yurman S, Dolfin T, Kogan A, Dollberg S, Arbel E, Goldberg M, Gur I, Naor N, Sirota L, Mogilner S, Zaritsky A, Barak M, Gottfried E. Arch Dis Child Fetal Neonatal Ed; 2000 Nov 13; 83(3):F177-81. PubMed ID: 11040164 [Abstract] [Full Text] [Related]
14. Early postnatal dexamethasone for the prevention of chronic lung disease in high-risk preterm infants. Romagnoli C, Zecca E, Vento G, De Carolis MP, Papacci P, Tortorolo G. Intensive Care Med; 1999 Jul 13; 25(7):717-21. PubMed ID: 10470576 [Abstract] [Full Text] [Related]
15. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Doyle LW, Ehrenkranz RA, Halliday HL. Cochrane Database Syst Rev; 2014 May 13; (5):CD001145. PubMed ID: 24825542 [Abstract] [Full Text] [Related]
16. A multicenter, randomized open study of early corticosteroid treatment (OSECT) in preterm infants with respiratory illness: comparison of early and late treatment and of dexamethasone and inhaled budesonide. Halliday HL, Patterson CC, Halahakoon CW, European Multicenter Steroid Study Group. Pediatrics; 2001 Feb 13; 107(2):232-40. PubMed ID: 11158452 [Abstract] [Full Text] [Related]
17. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. O'Shea TM, Kothadia JM, Klinepeter KL, Goldstein DJ, Jackson BG, Weaver RG, Dillard RG. Pediatrics; 1999 Jul 13; 104(1 Pt 1):15-21. PubMed ID: 10390254 [Abstract] [Full Text] [Related]
18. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates. Shah SS, Ohlsson A, Halliday H, Shah VS. Cochrane Database Syst Rev; 2003 Jul 13; (1):CD002058. PubMed ID: 12535425 [Abstract] [Full Text] [Related]
19. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. J Pediatr; 1990 Aug 13; 117(2 Pt 1):273-82. PubMed ID: 2199642 [Abstract] [Full Text] [Related]
20. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants. Shah SS, Ohlsson A, Halliday H, Shah VS. Cochrane Database Syst Rev; 2003 Aug 13; (2):CD002057. PubMed ID: 12804423 [Abstract] [Full Text] [Related] Page: [Next] [New Search]